株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

神経科学研究用抗体の世界市場

Neuroscience Antibodies and Assays

発行 Global Industry Analysts, Inc. 商品コード 908509
出版日 ページ情報 英文 183 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
神経科学研究用抗体の世界市場 Neuroscience Antibodies and Assays
出版日: 2019年10月01日 ページ情報: 英文 183 Pages
概要

当レポートでは、世界の神経科学研究用抗体市場を調査し、市場の定義と概要、市場動向・市場成長への各種影響因子の分析、競合企業と市場シェア、世界および地域・主要国別の市場規模の推移と予測、各種区分別の内訳、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界における競合企業の市場シェア
    • 世界における競合企業の市場シェア:シナリオ
  • 主要企業
  • 市場動向・成長推進因子
  • 世界市場の展望
    • 市場規模の推計・予測:地域/国別
    • 市場シェアの推移
    • 消耗品
    • 装置
    • 医薬品 & バイオテクノロジー企業
    • 大学 & 研究機関
    • 病院 & 診断センター
    • 免疫化学/免疫測定
    • 分子診断
    • 臨床化学
    • その他の技術

第3章 市場分析

  • 地域市場の分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州諸国
  • アジア太平洋
  • その他 (ROW)

第4章 競合企業

  • ABCAM PLC
  • BIO-RAD LABORATORIES
  • BIOLEGEND
  • CELL SIGNALING TECHNOLOGY
  • F. HOFFMANN-LA ROCHE AG
  • GENSCRIPT BIOTECH CORPORATION
  • MERCK KGAA
  • ROCKLAND IMMUNOCHEMICALS
  • SANTA CRUZ BIOTECHNOLOGY
  • SIEMENS HEALTHINEERS
  • TECAN GROUP
  • THERMO FISHER SCIENTIFIC

第5章 調査資料

目次
Product Code: MCP13582

Neuroscience Antibodies and Assays market worldwide is projected to grow by US$2.4 Billion, driven by a compounded growth of 9.9%. Consumables, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.6 Billion by the year 2025, Consumables will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$106.3 Million to the region's size and clout in the next 5 to 6 years. Over US$110.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Consumables will reach a market size of US$266.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.4% over the next couple of years and add approximately US$404 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abcam PLC; BioLegend, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; F. Hoffmann-La Roche AG; GenScript Biotech Corporation; Merck KgaA; Rockland Immunochemicals, Inc.; Santa Cruz Biotechnology, Inc.; Siemens Healthineers; Tecan Group Ltd.; Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Neuroscience Antibodies and Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Neuroscience Antibodies and Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Neuroscience Antibodies and Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Neuroscience Antibodies and Assays Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Consumables (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Consumables (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Consumables (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Instruments (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Instruments (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Instruments (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 11: Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 12: Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 14: Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
  • TABLE 15: Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 16: Hospitals & Diagnostic Centers (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 17: Hospitals & Diagnostic Centers (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 18: Hospitals & Diagnostic Centers (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Immunochemistry/Immunoassays (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 20: Immunochemistry/Immunoassays (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 21: Immunochemistry/Immunoassays (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Molecular Diagnostics (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 23: Molecular Diagnostics (Technology) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 24: Molecular Diagnostics (Technology) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Clinical Chemistry (Technology) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Clinical Chemistry (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Clinical Chemistry (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Other Technologies (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 29: Other Technologies (Technology) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 30: Other Technologies (Technology) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Neuroscience Antibodies and Assays Market Share (in %) by Company: 2019 & 2025
    • TABLE 31: United States Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Product: 2018 to 2025
    • TABLE 32: Neuroscience Antibodies and Assays Market in the United States by Product: A Historic Review in US$ Million for 2009-2017
    • TABLE 33: United States Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 34: United States Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
    • TABLE 35: Neuroscience Antibodies and Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
    • TABLE 36: Neuroscience Antibodies and Assays Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
    • TABLE 37: Neuroscience Antibodies and Assays Market in US$ Million in the United States by Technology: 2018-2025
    • TABLE 38: United States Neuroscience Antibodies and Assays Market Retrospective Analysis in US$ Million by Technology: 2009-2017
    • TABLE 39: United States Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 40: Canadian Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 41: Canadian Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 42: Neuroscience Antibodies and Assays Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 43: Canadian Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 44: Neuroscience Antibodies and Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 45: Canadian Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 46: Neuroscience Antibodies and Assays Market Analysis in Canada in US$ Million by Technology: 2018-2025
    • TABLE 47: Neuroscience Antibodies and Assays Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017
    • TABLE 48: Canadian Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 49: Japanese Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 50: Neuroscience Antibodies and Assays Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 51: Japanese Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 52: Japanese Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025
    • TABLE 53: Japanese Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2009-2017
    • TABLE 54: Neuroscience Antibodies and Assays Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
    • TABLE 55: Japanese Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2018-2025
    • TABLE 56: Neuroscience Antibodies and Assays Market in Japan in US$ Million by Technology: 2009-2017
    • TABLE 57: Japanese Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 58: Chinese Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 59: Neuroscience Antibodies and Assays Historic Market Analysis in China in US$ Million by Product: 2009-2017
    • TABLE 60: Chinese Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 61: Chinese Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025
    • TABLE 62: Neuroscience Antibodies and Assays Market Review in China in US$ Million by End-Use: 2009-2017
    • TABLE 63: Chinese Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 64: Neuroscience Antibodies and Assays Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025
    • TABLE 65: Chinese Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2009-2017
    • TABLE 66: Neuroscience Antibodies and Assays Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Neuroscience Antibodies and Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 67: European Neuroscience Antibodies and Assays Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 68: Neuroscience Antibodies and Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 69: European Neuroscience Antibodies and Assays Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 70: European Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 71: Neuroscience Antibodies and Assays Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 72: European Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 73: European Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 74: Neuroscience Antibodies and Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 75: European Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 76: European Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2018-2025
    • TABLE 77: European Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2009-2017
    • TABLE 78: Neuroscience Antibodies and Assays Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025
  • FRANCE
    • TABLE 79: Neuroscience Antibodies and Assays Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 80: French Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 81: French Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 82: Neuroscience Antibodies and Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
    • TABLE 83: French Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 84: French Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 85: French Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2018-2025
    • TABLE 86: French Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2009-2017
    • TABLE 87: French Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 88: Neuroscience Antibodies and Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
    • TABLE 89: German Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Product: 2009-2017
    • TABLE 90: German Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 91: Neuroscience Antibodies and Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
    • TABLE 92: German Neuroscience Antibodies and Assays Market in Retrospect in US$ Million by End-Use: 2009-2017
    • TABLE 93: Neuroscience Antibodies and Assays Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
    • TABLE 94: German Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by Technology: 2018-2025
    • TABLE 95: Neuroscience Antibodies and Assays Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017
    • TABLE 96: German Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 97: Italian Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2018-2025
    • TABLE 98: Neuroscience Antibodies and Assays Historic Market Analysis in Italy in US$ Million by Product: 2009-2017
    • TABLE 99: Italian Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 100: Italian Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025
    • TABLE 101: Neuroscience Antibodies and Assays Market Review in Italy in US$ Million by End-Use: 2009-2017
    • TABLE 102: Italian Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
    • TABLE 103: Neuroscience Antibodies and Assays Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025
    • TABLE 104: Italian Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2009-2017
    • TABLE 105: Neuroscience Antibodies and Assays Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 106: United Kingdom Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025
    • TABLE 107: Neuroscience Antibodies and Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017
    • TABLE 108: United Kingdom Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 109: United Kingdom Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2018 to 2025
    • TABLE 110: United Kingdom Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2009-2017
    • TABLE 111: Neuroscience Antibodies and Assays Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
    • TABLE 112: United Kingdom Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2018-2025
    • TABLE 113: Neuroscience Antibodies and Assays Market in the United Kingdom in US$ Million by Technology: 2009-2017
    • TABLE 114: United Kingdom Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 115: Rest of Europe Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018-2025
    • TABLE 116: Neuroscience Antibodies and Assays Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017
    • TABLE 117: Rest of Europe Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 118: Rest of Europe Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
    • TABLE 119: Neuroscience Antibodies and Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
    • TABLE 120: Rest of Europe Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 121: Rest of Europe Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2018-2025
    • TABLE 122: Rest of Europe Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2009-2017
    • TABLE 123: Neuroscience Antibodies and Assays Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025
  • ASIA-PACIFIC
    • TABLE 124: Neuroscience Antibodies and Assays Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 125: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2009-2017
    • TABLE 126: Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 127: Neuroscience Antibodies and Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
    • TABLE 128: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2009-2017
    • TABLE 129: Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
    • TABLE 130: Asia-Pacific Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2018-2025
    • TABLE 131: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2009-2017
    • TABLE 132: Asia-Pacific Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 133: Rest of World Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
    • TABLE 134: Rest of World Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2009-2017
    • TABLE 135: Neuroscience Antibodies and Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 136: Rest of World Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
    • TABLE 137: Neuroscience Antibodies and Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
    • TABLE 138: Rest of World Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
    • TABLE 139: Neuroscience Antibodies and Assays Market Analysis in Rest of World in US$ Million by Technology: 2018-2025
    • TABLE 140: Neuroscience Antibodies and Assays Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2009-2017
    • TABLE 141: Rest of World Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABCAM PLC
  • BIO-RAD LABORATORIES
  • BIOLEGEND
  • CELL SIGNALING TECHNOLOGY
  • F. HOFFMANN-LA ROCHE AG
  • GENSCRIPT BIOTECH CORPORATION
  • MERCK KGAA
  • ROCKLAND IMMUNOCHEMICALS
  • SANTA CRUZ BIOTECHNOLOGY
  • SIEMENS HEALTHINEERS
  • TECAN GROUP
  • THERMO FISHER SCIENTIFIC

V. CURATED RESEARCH

Back to Top